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Molecular evolutionof HBV genotypes A and D and subgenotypes A2 and D3 was studied on 132
isolates drawn between 1980 and 2005 from patients living in a homogenous geographical area. Evolutionary
rates and divergence dates were estimated and HBV demographic history was reconstructed by using a
statistical approach based on coalescent theory. The evolutionary rate of A2 was signiﬁcantly lower than that
of D3. The growth rate of D3 epidemic was signiﬁcantly faster than that of A2; both subgenotypes showed a
decreasing growth rate from the mid-1980s. Our data suggest that the important discrepancies observed in
the evolutionary rates of HBV genotypes A and D may reﬂect different population dynamics of their
epidemics. These results show the usefulness of phylodynamic studies in reconstructing the history of
epidemics due to highly variable DNA viruses, and in evaluating the long-term efﬁcacy of prophylactic
measures.
© 2008 Elsevier Inc. All rights reserved.Introduction
More than 350million people in theworld are infected by hepatitis
B virus (HBV), the prevalence of which remains high or very high in
developing countries, but is decreasing in the developed world. At the
end of the 1970s, more than 2% of the general population in Italy were
HBsAg-positive carriers (Stroffolini, 2005) but, since then, HBV
epidemiology has signiﬁcantly changed as a result of improvements
in socio-economic and hygienic conditions and the 1991 implementa-
tion of compulsory vaccination (Stroffolini, 2005). However, the
persistence of a reservoir of approximately 500,000–1 million carriers
(largely due to the cohort effect), and the low level of vaccination
coverage among high-risk subjects aged more than 25 years, mean
that HBV infection is still one of the country's major health problems
(Mele et al., 2002; Zanetti et al., 2006).
Although it is a DNA virus, HBV is characterised by considerable
genetic variability (Okamoto et al., 1987; Orito et al., 1989). Eightche “L. Sacco”, SezioneMalattie
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l rights reserved.genotypes (A–H) have so far been described, which differ from each
other by about 8% of nucleotides and have different geographic
distributions (Norder et al., 1992; Okamoto et al., 1988). In particular,
genotypes A and D are the most prevalent in subjects born in Western
countries: genotype A is mainly found in Europe and North America
(Chu et al., 2003; Kidd-Ljunggren et al., 2002), whereas genotype D is
widespread throughout the world and the prevalent genotype in the
Mediterranean basin (Southern Europe and North Africa) (Kidd-
Ljunggren et al., 2002; Norder et al., 2004). Subsequent studies have
shown that some genotypes can be further segregated into sub-
genotypes: strain A segregates into three subgenotypes, whereas
strain D shows a more complex phylogenesis clusterizing into ﬁve
subgenotypes and an intense heterogeneity at intrasubgenotypic level
(De Maddalena et al., 2007; Norder et al., 2004).
Genotype distribution may also differ on the basis of risk
behaviour. In a recent study, we reported a high prevalence of
genotype D and A in Italians with dual HIV-1/HBV infection, with
genotype D being the most prevalent among IVDUs, and genotype A
among men-having-sex-with-men (MSM) (Zehender et al., 2003). In
particular, subgenotype D3 was the most frequently found among
IVDUs and subgenotype A2 among MSM (De Maddalena et al., 2007).
The use of models for inferring the past demographic history of
populations on the basis of genealogical trees and improved methods
for estimating the evolutionary rates and divergence times of
heterochronous sequences (sequences sampled over relatively long
Table 1
Evolutionary rates and time of most recent common ancestor (tMRCA) estimates of HBV
A and D genotypes and subgenotypes A2 and D3
Genotype/
subgenotype
LnLa Evolutionary rate
(×10−4)
95%CI
(×10−4)
tMRCA
(year)
95%CI
(years)
A (A1–A2) 2627.89 0.90 0.12–1.7 1768 1560–1976
A2 2583 0.91 0.11–1.7 1943 1893–1993
D (D1–D4) 7841 3.67 2.85–4.49 1920 1902–1938
D3 6586.3 3.29 2.90–3.70 1935 1926–1944
a LnL: negative log-likelihood.
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basedmethods for studying the dynamics of viral populations at intra-
and inter-host level. This “phylodynamic” approach (Grenfell et al.,
2004) has been used to study the past/recent epidemiology of
infections due to highly variable RNA-viruses such as HCV (Pybus et
al., 2001, 2005; Verbeeck et al., 2006), HIV (Salemi et al., 2005; Walker
et al., 2005), West Nile virus (Snapinn et al., 2007), and foot-and-
mouth disease virus (Cottam et al., 2006) and, more recently, DNA
viruses (Kitchen et al., 2007).
In order to clarify the nature of their previously observed
different rates of heterogeneity, we have attempted to reconstruct
the epidemic history of HBV genotypes D and A. Samples collected
from HBsAg-positive Italian subjects infected with genotypes D and
A between 1980 and 2005 were used to estimate evolutionary
rates and to infer demographic parameters such as the number of
infections and the rate of growth, in the light of current knowledge
concerning the epidemiology of hepatitis viruses.
Results
Evolutionary rates and divergence dates
The evolutionary rates of genotypes A and D were separately
estimated for HBV polymerase (P) and surface antigen (PreS/S) genes.Fig. 1. Rooted genealogies of HBV subgenotypes A2 and D3 using sequences 1182 nt long, esti
have a proportional relationship between branch lengths and time. The main clades are h
signiﬁcance of the clades (bootstrap value ≥65% and/or Likelihood ratio test for branch lengThe results were very similar because the overlapping region of the
two genes was analysed, but the P sequences gave better estimates
with narrower 95% conﬁdence intervals (CIs) and are reported in the
Table 1. The estimates were also similar between the genotype A
dataset as a whole and the subgenotype A2 dataset, and between the
genotype D and subgenotype D3 datasets. On the contrary, the
evolutionary rates of genotype D (3.7×10−4 subs/site/year) and
subgenotype D3 (3.3×10−4 subs/site/year) were higher than those of
genotype A and subgenotype A2 (0.9×10−4 subs/site/year) and these
differences were signiﬁcant as shown by the non-overlapping
conﬁdence limits (Table 1).
Accordingly, the times of the most recent common ancestor
(tMRCA) were dated 1768 (95%CI: 1560–1976) for genotype A andmated by means of maximum likelihood under the SRDT model using Tipdate. The trees
ighlighted: red for A2 and blue for D3. Asterisks on the branches indicate statistical
th of zero, Pb0.001 — De Maddalena et al., 2007).
86 G. Zehender et al. / Virology 380 (2008) 84–901920 (95%CI: 1902–1938) for genotype D. More similar dates were
obtained for subgenotypes, 1943 (95%CI: 1893–1993) for A2 and 1935
(95%CI: 1926–1944) for D3.
Tipdate tree analysis
Analysis of the tipdate trees (Fig. 1) of subgenotype A2 showed a
main clade dated 1960 (95%CI: 1927–1993) that further segregated
into different monophyletic groups. One of these originated in about
1966 (95%CI: 1940–1991, red in Fig. 1) and included strains mainly
derived from subjects who were HIV-1 positive (9/14, 64.3%) and/or
MSM (6/14, 42.9%): more speciﬁcally, the clade included 90% of the
HIV-1 positive isolates and 66.7% of the MSM isolates. In order to
eliminate the presence of the lamivudine-resistance associated
mutations in positions rt204 and rt180 of the P sequence in the
majority of the A isolates as a possible confounding factor, these sites
were removed before the analysis without changing the topology or
time estimates [data not shown].
Analysis of the tipdate tree of subgenotype D3 showed two main
clades originating in about 1950 (95%CI: 1945–1956, Fig.1), and several
smaller clades originating in the same interval of years. Interestingly,
13/16 IVDU isolates (81.2%) clustered in a subclade originating in 1971
(95%CI: 1968–1973, blue in Fig. 1), which also included two hetero-
sexual, one iatrogenic and eleven community acquired infections; the
same subclade included half of the 14 HIV-1 positive individuals. All of
the isolates included in this subclade were characterised by the
presence of mutations S90T in PreS1 (corresponding to V93D in the
spacer of P protein), T125M and P127T/A in S protein (the last one
corresponding to rtS135Y/C), L116F and P120S in the spacer region of P
protein and rtC256S and rtV266I/R in the reverse transcriptase. All but
two isolates also had the mutation T31A in PreS2 corresponding to
N142S in spacer of P protein. Themutation T/M in position 125 of the S
protein appeared at the 1960 node (95%CI: 1955–1965), whereas the
tMRCA of all of the other mutations was 1971.
All the other clades originating in 1940s–1950s included mainly
HIV-1 negative subjects with community acquired (about 80%)
infections.
Demographic estimates
Different demographic hypotheses were tested by means of
maximum likelihood analysis using the HBV clock-like trees with
non-contemporary sequences. As shown in Table 2, both the genotype
D dataset as a whole and the subgenotype D3 dataset best ﬁtted the
logistic model of growth (P=0.002 and Pb0.001 by LRT). In the case of
genotype A, the logistic model was preferred for the A2 sequences
(Pb0.01 by LRT), but the dataset as a whole best ﬁtted an expansion
model (Pb0.001 vs. exponential model by LRT).Table 2
Growth model, negative log-likelihood (LnL), likelihood ratio test (LRT) and demograp
in parentheses)
Genotype/subgenotype Selected model LnL LRT Pa N (0)b
A Expansion 269.832 11.3 1700
b0.001 (633–5444)
A2 Logistic 266.608 9.6 580
b0.01 (318–1340)
D Logistic 697.869 9.5 2591
0.002 (1523–6021)
D3 Logistic 578.700 32.7 1286
b0.001 (912–1897)
a Comparison with the simpler nested model.
b N (0): effective number of infections at present.
c r: growth rate.
d α: population size at t=∞ in expansion model; c: logistic shape parameter.
e R0: basic reproductive number for average duration of the infectiousness (D) equal to 1
f λ: doubling time for epidemic in years.The estimates of the demographic parameters for genotypes A and
D, and subgenotypes A2 and D3, using the selected models, are
reported in Table 2. The growth rate (r) and the basic reproductive
number (R0) (for D=10 or 30 years) of subgenotype D3 were always
signiﬁcantly higher than those of subgenotype A2, as shown by the
non-overlapping conﬁdence limits. In particular, the growth rate of
subgenotype D3was 1.75-fold faster than that of subgenotype A2 (95%
CI of r=0.2–0.3 for D3 and 0.09–0.19 for A2). The R0 calculated for the
plausible average duration of the infection showed that each primary
case with the D3 subgenotype generated 1.4–1.6 times more
secondary cases than each primary case with A2, and the epidemic
doubling time (λ) estimate was about 5 years for A2 and about 3 years
for D3.
Skyline plot analysis
The skyline analysis of the non-parametric estimates of N (t)
(Fig. 2) showed that the exponential growth of the subgenotype A2
epidemic started in our population in 1960, raised gradually over time,
until the equilibrium prevalence reaching a peak in 1986. Since 1994,
there has been a 15.7-fold decrease in the number of infections. The
D3 epidemic began in the 1940s and grew exponentially until the
1980s when the number of infections reached the plateau and the
growth rate slowed down. At the peak the number of D3 infections
was twice that of A2 (Fig. 2).
Discussion
As a result of the use, during viral replication, of a reverse
transcriptase lacking the proofreading function, the genetic variability
of HBV is greater than that of any other DNA virus (Duffy et al., 2008).
Previous studies have suggested evolutionary rates ranging from
1.5×10−5 to 7.72×10−4 subs/site/year (Fares and Holmes, 2002;
Hannoun et al., 2000; Okamoto et al., 1987; Orito et al., 1989; Osiowy
et al., 2006; Zhou and Holmes, 2007).
Our study was based on a homogenous series of HBV-infected
subjects from the same geographical area whose samples were
collected over a period of 25 years (1980–2005). The estimated
evolutionary rates of genotype D and subgenotype D3 (in the order of
3×10−4) were more than three times higher than those of genotype A
and subgenotype A2 (in the order of 0.9×10−4), and the absence of any
overlap in the 95% CIs supports a statistically signiﬁcant difference
between the two genotypes and subgenotypes.
As recently shown by other authors (Fares and Holmes, 2002; Zhou
and Holmes, 2007), recombination occurs frequently among hepadna-
viruses. Recombination can affect both phylogeny and the estimation of
the tMRCA. In particular it has been shown that the presence of only
small levels of recombination in the alignment, lets to more frequenthic parameter estimates (see the legend below) for the analysed data sets (95%CI
rc α/cd R0e (D=10) R0 (D=30) λf
0.075 0.028 1.7 3.2 9.2
(0.04–0.11) (0.024–0.12) (1.4–2.1) (2.2–4.6) (6.3–17.3)
0.144 0.019 2.4 5.3 4.8
(0.09–0.19) (0.0014–0.24) (1.9–2.9) (3.7–6.7) (3.6–6.9)
0.115 0.050 2.5 4.5 6.0
(0.09–0.13) (0.011–0.36) (1.9–2.3) (3.7–4.9) (5.1–7.4)
0.252 2.5×10−5 3.5 8.6 2.7
(0.2–0.3) (1.8×10−6–4.3×10−4) (3.0–4.0) (7–10) (2.3–3.3)
0 or 30 years.
Fig. 2. Skyline plots representing non-parametric (solid line) and induced estimates (dashed line) of N (t) using the polymerase gene of HBV subgenotypes A2 and D3. Genetic
distances were transformed into a time scale of years using the evolutionary rates inferred by means of maximum likelihood. Ordinates: N (t); abscises: time (years).
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reasons we screened our alignment for recombination with different
programs and excluded recombinant isolates from further analysis.
Like other authors (Pybus et al., 2005; Salemi et al., 2005), we found
that the molecular clock hypothesis was easily rejected in each of our
datasets [data not shown]. However, simulation studies have shown
that, when there is small amount of rate heterogeneity between
lineages, estimated substitution rates are still reliable indicators of the
average rate of evolution and can still be used to infer divergence times
correctly (Jenkins et al., 2002).
On the basis of our estimates, we inferred that the origin of the D
genotype is relatively recent (about 85 years ago), as well that of
subgenotypes D3 and A2 (about 70 and 65 years ago).
In a previous study, we found major differences in the viral
heterogeneity of HBV genotypes, with genotype D showing more
polymorphism than HBV G or A (De Maddalena et al., 2007). Here we
report a marked difference in the evolutionary rates of genotypes A
and D and subgenotypes A2 and D3.
It is known that genotype D has a highly complex phylogenesis,
which has been attributed to its worldwide distribution and/or its
possible ancient origin (Norder et al., 2004). Our data seem to suggest
that other factors, intrinsic to the virus and/or linked to the population
dynamics of the epidemics, may account for both the high evolu-
tionary rate and complex phylogeny of this genotype.
Demographic analysis showed that the D3 epidemic grew twice as
rapidly as that due to A2, with both showing a logistic trend consistingof a phase of exponential increase of infections followed by a plateau
at equilibrium prevalence. Our data suggest that the exponential
growth of the D3 subgenotype began in Italy sometime between 1945
and 1956 (more probably in the early '50s), which coincides with the
appearance of two major and several minor clades in the tipdate tree,
including mainly HIV-1 negative subjects with community acquired
infections. The equilibrium phase was reached during the 1960s and
1970s, when a new clade associated with IVDU and HIV-1
positivity emerged.
HBV D3 is themost frequent strain found among IVDUs, inwhom it
is characterised by a number of S and P mutations (De Maddalena et
al., 2007): in particular, the mutation (T/M) in residue 125 of S protein
has also been reported by others (Norder et al., 2004). We have
previously described additional mutations in PreS1 and PreS2
(De Maddalena et al., 2007) and now in P protein, characterising the
same IVDUs associated strain. Analysis of the tipdate tree suggests
that the ancestor of this strain was a single T125M mutant that
probably emerged between 1955 and 1965, and subsequently spread
among IVDUs acquiring new mutations.
The exponential growth of subgenotype A2 took place in the 1960s,
and reached a plateau in the 1980s. We have previously reported that
genotype A and subgenotype A2 were the most prevalent HBV strains
among MSM in Italy (De Maddalena et al., 2007). Interestingly, we
found that the A2 sequences from a 67% of the MSM (and a 90% of the
HIV-1 positive individuals) formed a separate clade originating
around the year 1966.
Table 3
Demographic, virological and risk data of the 132 HBV-infected subjects included in the
study
Characteristics
Median age: years (range) 38.5 (15–84)
Gender: F/Ma 1/2.2
Genotype/subgenotype: No.b
A (37) A1=2; A2=35
D (95) D1=5; D2=9; D3=79; D4=2
HIV-1: No. (%)
Positive 31 (23.5)
Negative 71 (53.8)
NDc 30 (22.7)
Risk: No. (%)
MSMd 15 (11.4)
HCe 11 (8.3)
Transfusion 10 (7.6)
IVDUsf 19 (14.4)
Unknown 77 (58.3)
Sampling dates: No. (%)
1980–1989 30 (22.7)
1990–1999 28 (21.2)
2000–2005 74 (56.1)
a F: female; M: male.
b No.: number of patients.
c ND: not determined (subjects drawn before the availability of anti-HIV-1 tests).
d MSM: men-having-sex-with-men.
e HC: heterosexual contacts.
f IVDUs: intravenous drug users.
88 G. Zehender et al. / Virology 380 (2008) 84–90In brief, strain D3 penetrated earlier and its epidemic grew
rapidly, with a doubling time of about 3 years, whereas the A2
epidemic started later and grew slower, with a doubling time of
about 5 years.
On the basis of the growth rate (r), it is possible to estimate the “basic
reproductive number” R0 of an infection (Pybus et al., 2001), which
represents the mean number of secondary cases caused by a single
primary case in a population without immunity. The R0 for the D3 and
A2 subgenotypes were calculated for a plausible duration of infection in
carriers (10–30 years). In addition to infectiousness duration, a number
of other factors may affect R0, including the modality and efﬁciency of
the transmission of the infection into the population. Various estimates
of theR0 ofHBVhave beenpublished (Edmunds et al.,1996), andMedley
has recently suggested that it lies between 1 and 2 in countrieswith low
endemicity (Medley et al., 2001). Italy, which reported a more than 2%
prevalence of HBV carriers before the introduction of mandatory mass
vaccination (in the year 1991), was included among the countries with
medium endemicity. Even considering the shortest duration of the
infection, the R0 estimates from our data were higher than 2 for both
subgenotypes, but D3 had a signiﬁcantly greater basic reproductive
number than A2. This may be due to the different pattern of
transmission of HBV subgenotypes in the population. On the basis of
our observations, in fact, A2 mainly spread through the sexual route,
whereas D3 through the parenteral route (blood transfusion, unsafe
injections, etc.). Interestingly, our estimate of R0 for HBV A2 (2.4 for
D=10 years) is very close to the R0=2.6 calculated in homosexual men
living in Western countries using a recently developed model
(Kretzschmar et al., 2002).
In brief, our data suggest that, like HCV infection (Prati, 2006),
the spread of the two most prevalent HBV genotypes/subgenotypes
coincided with two distinct epidemic waves. The ﬁrst started
around the time of World War II when the use of unsafe medical
injections was common (Drucker et al., 2001) and there was an
increase in the use of blood and blood derivatives for transfusion
purposes (Giangrande, 2000; Prati, 2006) without any screening for
HBsAg until the early 1970s (Gerlich and Caspari, 1999). During this
period the HBV epidemic grew rapidly and was mainly due to
subgenotype D3. The second epidemic took place in the 1960s and
1970s, involved subjects at high behavioural risk such as intrave-
nous drug users or people with multiple sexual contacts (particu-
larly MSM), and was characterised by the introduction of new viral
strains (such as subgenotype A2) and the expansion of pre-existing
variants (such as the IVDU-associated mutants of HBV-D3) via
different transmission routes. From half 1980s the growth rate of
both epidemics slowed down and even a decrease of the number
of infections starting in 1997 was observed in the case of
subgenotype A. This is in agreement with a documented sharp
decrease in the incidence of acute hepatitis B in Italy (Spada et al.,
2001) and other Western countries (Wasley et al., 2007) in the
same period of time, probably due to various factors such as
improved socio-economic conditions, educational campaigns
against AIDS and the introduction of mass anti-HBV vaccination.
This study shows the potential usefulness of phylodynamic studies
in reconstructing the history of the epidemics due to highly variable
DNA viruses, but also in evaluating the long-term efﬁcacy of
prophylactic measures such as vaccination and/or behavioural
changes.
Patients and methods
Patients and datasets
Sequences of HBV genotypes D and A were obtained from the
serum samples of 132 HBsAg and HBV DNA-positive subjects
attending four hospitals in north-west Italy between 1980 and 2005.
Samples drawn from patients born outside Italy, or who were positivefor genotypes other than D or A or recombinant strains (see below),
were not included in the analysis. Four sequence datasets were
considered: two including all genotype A sequences (No.=37) and all
genotype D sequences (No.=95); and two including only the
subgenotype A2 (No.=35) and subgenotype D3 (No.=79) sequences.
The demographic/risk characteristics of the study population are
shown in Table 3.
HBV-DNA ampliﬁcation and sequencing
Viral DNA, extracted from serum using the High Pure PCR Template
Preparation Kit (Roche Diagnostics GmbH, Mannheim, Germany), was
ampliﬁed using a previously described multiple nested-PCR protocol
to obtain the HBV polymerase (P) and surface antigen (PreS/S)
sequences (DeMaddalena et al., 2007). Brieﬂy, ﬁve sets of degenerated
primers were used to obtain two large outer fragments (from nt 2474
to nt 1108 of full-length HBV genome) and three inner and partially
overlapping sequences generating a 1365 nt product.
The three ampliﬁed inner fragments were sequenced in sense and
antisense directions by means of the dideoxy method using the
automated DNA Sequencer 3100 Genetic Analyzer (Applied Biosys-
tems, Foster City, CA, USA). Editing these sequences, for each single
patient, we obtained a 1182 nt fragment including about one-half of
the HBV-P gene and about 90% of the overlapping PreS/S gene, and
used it for making phylogenetic estimates. The deduced amino acid
sequences were aligned with reference strains by subgenotype, and
the majority-rule consensus sequence was calculated. We restarted
numbering PreS/S proteins at the ﬁrst codon position of each domain.
We used the nomenclature proposed by Stuyver et al. for P protein
(Stuyver et al., 2001).
In order to identify and exclude from the analysis recombinant
strains, we used the RDP3 program implementing ﬁve different
methods: GENECONV, RDP, SiScan, Bootscan and MaxChi, with a
highest acceptable P-value of 0.05 and a multiple comparison
correction by Bonferroni method. Sequences resulting recombinant
with at least three methods were excluded from further analysis.
The sequences have been submitted to GenBank (accession numbers:
EF514251 to EF514260, EF514262 to EF514278, EF514283 and EF514284,
89G. Zehender et al. / Virology 380 (2008) 84–90EF514287 to EF514304, EF514306 to EF514311, EF514313, EF514315 to
EF514333, EF514335 to EF514337, EU908789 to EU908844).
Phylogenetic estimates and calculated evolutionary rates
The genealogies of two datasets of sequences of genotype A or D
were estimated separately using maximum likelihood (ML) as
implemented in PAUP⁎ (Swofford D, 1998, Sinauer Ass. Inc. Publ.),
and the best ﬁtting substitution models and parameters were tested
using the hierarchical likelihood ratio test (LRT) implemented in
Modeltest 3.07 software (Posada and Crandall, 1998). An HKY model
(Hasegawa et al., 1985) with a transition/transvertion ratio of 1.51 and
γ-distributed rates among sites (α-shape parameter=0.19) was
selected for the A sequences, and a general time-reversible (GTR)
model plus invariable sites (proportion=0.48) and γ-distributed rates
among sites (α-shape parameter=0.71) for the D sequences.
The ML trees were heuristically searched by means of PAUP⁎ using
a stepwise addition algorithm to construct the starting tree and the
TBR algorithm for branch swapping. Each tree was rooted using HBV
genotype F (Acc.N. AB036910 — Nakano et al., 2001) as the outgroup.
As the dates of isolation of our sequences were known, we used the
TipDate (Rambaut, 2000) program for the ML estimates of evolu-
tionary rates, divergence dates and conﬁdence intervals under a
single-rate dated tips (SRDT) model, which is more relaxed than the
single-rate molecular clock model. The statistical test was the
likelihood ratio test between SRDT and the unconstrained model
(Rambaut, 2000).
Inferring demographic history
The past epidemiology of HBV was estimated using a statistical
method based on coalescent theory, according to which the demo-
graphic history of a population can be inferred by the shape of a gene
genealogy obtained by analysing a small sample of it (Kingman, 2000).
The assumptions of the method employed is that genealogy is
unaffected by recombination, that the evolutionary rate remains the
same throughout the genealogy, and that the sample size is
considerably less than the entire population.
The underlying mathematics have been described in great detail
elsewhere (Pybus et al., 2000). Using parametric and non-
parametric approaches, it is possible to estimate the parameters
ϑ, corresponding to N (0)μ, and ρ, being r/μ, where N (t) is the
effective number of infections at time t (t=0 at present, and tN0 in
the past), μ the evolutionary rate, and r the growth rate of the
population. Six demographic models were considered: constant,
exponential, expansion and, logistic, piecewise logistic and piece-
wise expansion growth. Equations relating N (t) to other demo-
graphic parameters under different models have been reported
elsewhere (Pybus et al., 2005).
The relative value (and 95% conﬁdence interval) of ϑ and ρ
maximising the likelihood were obtained for each model. A likelihood
ratio test was used to test the goodness of ﬁt of the data to eachmodel.
Parameters, c (the shape of the curve) and α (the population size at
t=∞), which are not inﬂuenced by the time scale, were obtained for
logistic and expansion growth, respectively. The logistic shape
parameter correlates with the carrying capacity of the population
(Pybus et al., 2001).
Non-parametric estimates of epidemic history were obtained by
means of skyline plotting (Pybus et al., 2000). The plots show the
number of effective infections (N (t) in the ordinates) versus time (t in
the abscises). The parametric and non-parametric curves were
indicated simultaneously.
R0 (deﬁned as the basic reproductive number, and indicating the
mean number of secondary cases generated by a single primary case)
was calculated from r using the equation R0= rD+1, where D is the
average duration of infectiousness (Pybus et al., 2001). The doublingtime of the epidemic was given by the relation λ=ln(2) / r (Walker et
al., 2005). All calculations and skyline plots were obtained using
GENIE (Pybus and Rambaut, 2002).References
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